ADRA2B antibody
Quick Overview for ADRA2B antibody (ABIN7672627)
Target
See all ADRA2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- ADRA2B-Specific antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- adrenergic, alpha-2B-, receptor
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:200-1:1000, IHC: 1:50-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Alternative Name
- ADRA2B
-
Background
-
Synonyms: Alpha-2B adrenergic receptor|Alpha-2 adrenergic receptor subtype C2|Alpha-2B adrenoreceptor (Alpha-2B adrenoceptor, Alpha-2BAR)|ADRA2B|ADRA2L1|ADRA2RL1
Background: ADRA2B, also named as ADRA2L1 and ADRA2RL1, belongs to the G-protein coupled receptor 1 family. ADRA2B mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The antibody is specific to ADRA2B.
-
Molecular Weight
- 50 kDa
-
Gene ID
- 151
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-